Aurobindo`s Unit Receive UK Approval for Biosimilar Breast Cancer
27 Aug 2025 //
BUSINESS STD
CuraTeQ Biologics`s Dazublys Receives Approval in Europe
30 Jun 2025 //
EMA
Aurobindo arm’s Biosimilar Gets Marketing Nod From U.K.’s MHRA
14 May 2025 //
THEHINDU
CuraTeQ Biologics gets positive opinion for Dazublys biosimilar
28 Apr 2025 //
INDPHARMAPOST
CuraTeQ Biologics finishes Phase 1 study of Denosumab biosimilar
09 Apr 2025 //
INDPHARMAPOST
CuraTeQ Biologics`s Dyrupeg Receives Approval in Europe
28 Mar 2025 //
EMA
CuraTeQ Biologics receives positive opinion for biosimilar Dyrupeg from EMA
03 Feb 2025 //
INDPHARMAPOST